DOKTA.E — Doktas Dokumculuk Ticaret ve Sanayi AS Balance Sheet
0.000.00%
- TRY7.49bn
- TRY13.32bn
- TRY11.94bn
Annual balance sheet for Doktas Dokumculuk Ticaret ve Sanayi AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 34.3 | 24.1 | 170 | 224 | 225 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 354 | 713 | 862 | 1,070 | 1,352 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 718 | 1,672 | 2,624 | 3,579 | 3,670 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,223 | 2,363 | 4,144 | 7,449 | 10,796 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2,046 | 4,233 | 7,100 | 11,601 | 15,102 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 970 | 1,793 | 3,062 | 3,791 | 5,631 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,832 | 3,286 | 4,919 | 7,134 | 9,333 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 213 | 946 | 2,182 | 4,466 | 5,769 |
Total Liabilities & Shareholders' Equity | 2,046 | 4,233 | 7,100 | 11,601 | 15,102 |
Total Common Shares Outstanding |